Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Dose, Double-Blind, Two-Period, Crossover, Comparative Pharmacokinetic Study of Three Tocilizumab Products Administered by the Subcutaneous Route to Normal Healthy Volunteers

NCT04885829 is registered in ClinicalTrials.gov with Syneos Health as lead sponsor.

NCT NCT04885829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04885829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Dose, Double-Blind, Two-Period, Crossover, Comparative Pharmacokinetic Study of Three Tocilizumab Products Administered by the Subcutaneous Route to Normal Healthy Volunteers
Lead sponsor
Syneos Health
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2021
Completion date
May 4, 2023
Enrollment
300 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell arteritis, rheumatoid arthritis